Can Psilocybin Therapy Help Me?
If you are suffering from depression, anxiety, PTSD, or other crisis we believe psilocybin therapy services can help you find relief. Why? Because research supports our view, and our client testimonials prove the results can be there. A number of factors make the outcome more likely for you.
Setting an Intention:
Setting an intention is so important to the process. The more clearly defined your intention, the more likely your outcome will be positive.
Active Preparation:
The more and better you prepare the more likely you will reach your intended goals. Our facilitators will provide insight and techniques on how you can prepare for your journey.
Integration:
Intention and preparation are key to entering into the journey. Afterwards integrating the experience into your life becomes your primary focus. The integration process sometimes takes a long time. We will always be available to answer your integration questions.
“It probably saved my son’s life.”
“My experience addressed one of my root issues, my unconscious blocking of emotions.”
“55 years of fear and anxiety are gone; I feel like life is worth living again.”
“I stopped ruminating over past events.”
“I understand how I’ve been a sponge for other people’s problems. I feel liberated now.”
“It changed my life.”
“I felt like I was dying. Afterward, I was able to break through with my aging father after 40 years of blockage.”
“I lost control, I was terrified, and I came to realize I was blocking information I could not look at. With the help of my facilitator, I was able to break past what I did not want to look at. Facing these issues resulted in the most cathartic experience I could ever have.”
“I’m ready to die gracefully.”
What Does Research Say?
Psilocybin Reduces Anxiety and Depression about Death
“Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial.“ John’s Hopkins 2016
Grob, C. S., Danforth, A. L., Chopra, G. S., Hagerty, M., McKay, C. R., Halberstadt, A. L., & Greer, G. R. (2011). Pilot study of psilocybin treatment for anxiety in patients with
advanced-stage cancer.
Psychedlics Reduce Effects of PTSD
Mithoefer, M. C., Wagner, M. T., Mithoefer, A. T., Jerome, L., & Doblin, R. (2010). The safety and efficacy of {3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study. Journal of Psychopharmacology, 25(4), 439-452.
Mithoefer, M. C., Mithoefer, A. T., Feduccia, A. A., Jerome, L., Wagner, M., Wymer, J., … & Doblin, R. (2019). 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial. The Lancet Psychiatry, 6(9), 707-719.
Reduces Anxiety and Depression
Carhart-Harris, R. L., Bolstridge, M., Rucker, J., Day, C. M., Erritzoe, D., Kaelen, M., … & Nutt, D. J. (2016). Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. The Lancet Psychiatry, 3(7), 619-627.
Griffiths, R. R., Johnson, M. W., Carducci, M. A., Umbricht, A., Richards, W. A., Richards, B. D., … & Klinedinst, M. A. (2016). Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. Journal of Psychopharmacology, 30(12), 1181-1197.
Ross, S., Bossis, A., Guss, J., Agin-Liebes, G., Malone, T., Cohen, B., … & Soskin, R. (2016). Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: A randomized controlled trial. Journal of Psychopharmacology, 30(12), 1165-1180.
Johnson, M. W., Garcia-Romeu, A., Cosimano, M. P., & Griffiths, R. R. (2014). Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction. Journal of Psychopharmacology, 28(11), 983-992.
Reducing Alcohol Dependance
Bogenschutz, M. P., Forcehimes, A. A., Pommy, J. A., Wilcox, C. E., Barbosa, P., & Strassman, R. J. (2015). Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study. Journal of Psychopharmacology, 29(3), 289-299.
Garcia-Romeu, A., Davis, A. K., Erowid, E., Erowid, F., Griffiths, R. R., & Johnson, M. W. (2019). Cessation and reduction in alcohol consumption and misuse after psychedelic use. Journal of Psychopharmacology, 33(9), 1088-1101.
Bogenschutz, M. P., Johnson, M. W., & Classic, R. K. (2018). Psilocybin-assisted treatment for alcohol use disorder: A proof-of-concept study. Journal of Psychopharmacology, 32(7), 779-791.
Johnson, M. W., Garcia-Romeu, A., Cosimano, M. P., & Griffiths, R. R. (2014). Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction. Journal of Psychopharmacology, 28(11), 983-992.